Results 1 to 10 of about 9,115 (218)

Epidural lidocaine, butorphanol, and butorphanol – lidocaine combination in dromedary camels

BMC Veterinary Research, 2023
Background The use of general anesthesia in dromedary camels is constrained by risks related to decubitus. Caudal epidural analgesia is an alternative convenient technique providing loco-regional analgesia for numerous invasive and noninvasive painful ...
Ayman El Nahas, Adel Ibrahim Almubarak, Usama Hagag   +2 more
doaj   +3 more sources

Duration of sedation effects on the ACTH stimulation test in healthy dogs. [PDF]

PLoS ONE
BackgroundSedation is frequently required in dogs for diagnostic workups and patient safety. Yet, sedation affects serum cortisol levels; butorphanol elevates cortisol, while dexmedetomidine reduces it dose dependently.
Jake Salzman, Shelly Olin, Alejandro Esteller-Vico, Luca Giori   +3 more
doaj   +2 more sources

Target-controlled infusions of butorphanol worsen hemodynamics in isoflurane-anesthetized cats [PDF]

Frontiers in Veterinary Science
IntroductionPartial intravenous anesthesia can be used to reduce the adverse effects of inhalant anesthetics, and opioids are often used in this context in dogs and cats.
Bruno H. Pypendop, Alessia Cenani, Marcela L. Machado, Linda S. Barter   +3 more
doaj   +2 more sources

Anti-tumor activity of butorphanol in colorectal cancer via targeting SIGMAR1 [PDF]

Discover Oncology
Colorectal cancer (CRC) stands for a prevailing gastrointestinal neoplasm, concomitant with considerable occurrence and lethality rate. Butorphanol, a synthetic opioid analgesic medication targeting the opiate receptor, has been recently reckoned to ...
Xueqi Hou, Longfei Qu, Yong Xu, Jie Liu, Jianlian Guo   +4 more
doaj   +2 more sources

Butorphanol Promotes Macrophage Phenotypic Transition to Inhibit Inflammatory Lung Injury via κ Receptors

Frontiers in Immunology, 2021
Acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) is characterized by diffuse inflammation of the lung parenchyma and refractory hypoxemia.
Guangxin Luan, Fan Pan, Lina Bu, Kaixuan Wu, Aizhong Wang, Xiaotao Xu   +5 more
doaj   +1 more source

Intravenous butorphanol as an adjunct to patient-controlled epidural analgesia with ropivacaine and sufentanil in labor: a randomized controlled study

Clinical and Experimental Obstetrics & Gynecology, 2022
Background: Butorphanol was safely used for obstetric analgesia for many years. We attempted to determine if it increases the analgesic effect during patient-controlled epidural labor analgesia (PCEA) and if it affects the labor-process.
Ting Zhou, FengYuan Nong, MengXia Wang, ZhaoJia Liang, YaLan Li   +4 more
doaj   +1 more source

Butorphanol

, 2006
europepmc   +2 more sources

Efficacy of dexmedetomidine versus midazolam when combined with butorphanol for sedation and analgesia during burn dressing changes: A randomized clinical trial

Frontiers in Pharmacology, 2022
Objective: The aim of this study was to compare dexmedetomidine-butorphanol (DB) and midazolam-butorphanol (MB) combinations for sedation, and analgesia in burn patients undergoing dressing changes.Methods: A total of 56 ASA I–II burn patients were ...
Xianchao Ding, Hengfeng Cui, Peng Ma, Xi Chen, Yan Sun, Minye Qu, Zhixin Yan   +6 more
doaj   +1 more source

Comparison of ED95 of Butorphanol and Sufentanil for gastrointestinal endoscopy sedation: a randomized controlled trial

BMC Anesthesiology, 2020
Background Butorphanol, a synthetic opioid partial agonist analgesic, has been widely used to control perioperative pain. However, the ideal dose and availability of butorphanol for gastrointestinal (GI) endoscopy are not well known.
Xiaona Zhu, Limei Chen, Shuang Zheng, Linmin Pan   +3 more
doaj   +1 more source

Butorphanol Suppresses the Proliferation and Migration of Osteosarcoma by Promoting the Expression of piRNA hsa_piR_006613

Frontiers in Oncology, 2022
Butorphanol, a partial agonist of opioid receptor κ 1 receptor, can and is widely used as an analgesic drug to relieve moderate and severe pain in clinic. Osteosarcoma is one of the most common malignant bone tumor in adolescents under the age of 20.
Pengfei Cui, Deqian Xin, Fu Li, Lin Deng, Yujie Gao   +4 more
doaj   +1 more source